SLC6A3 and Alzheimer disease: The dopamine transporter (DaT) can be labeled for use with PET or single-photon emission computed tomography (SPECT) imaging and can assist in distinguishing AD from dementia with Lewy bodies and Parkinson’s disease dementia; the latter two are characterized by dopamine transporter depletion [58].